Fatigue on tirzepatide may involve more than appetite suppression alone. This article explores how dehydration, heart rate changes, reduced calorie intake, and digestive slowing may combine to produce systemic exhaustion during Mounjaro treatment.
Some patients stop Ozempic and other weekly GLP-1 drugs despite improved blood sugar results. Persistent nausea, appetite suppression, treatment fatigue, and lifestyle burden may all contribute to long-term discontinuation.
GLP-1 medications can produce dramatic weight loss, but many patients report fatigue, morning nausea, and reduced workplace performance during dose escalation. Here’s what current evidence reveals about the biology behind these symptoms — and why slower titration may improve tolerability without sacrificing results.